Skip to content

Analysis of risk factors and prediction model of disease progression in people with impaired glucose tolerance (IGT)

Analysis of risk factors and prediction model of disease progression in people with impaired glucose tolerance (IGT)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000040023
Enrollment
Unknown
Registered
2020-11-18
Start date
2020-11-20
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impaired glucose tolerance

Interventions

Sponsors

The Affiliated Hospital of Changchun University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. People with impaired glucose tolerance; 1) Aged 18 to 75 years; 2) Meet the diagnostic criteria of Western medicine for IGT; 4) Informed consent has been signed. 2. Healthy people: 1)Aged 18 to 70 years; 2) According to the diagnostic criteria of healthy people, the constitution of traditional Chinese medicine was judged as peaceful constitution; 3) There was no history of chronic diseases, such as diabetes and its pre status, hypertension, hyperlipidemia, hyperuricemia, overweight / obesity, coronary heart disease, etc; 4) Physical examination and blood glucose test data were normal; 5) Informed consent has been signed.

Exclusion criteria

Exclusion criteria: 1) People who have used hypoglycemic drugs continuously in recent 3 months; 2) Patients who have been diagnosed with type 1 diabetes, type 2 diabetes, gestational diabetes, secondary diabetes and other special types of diabetes; 3) Patients with severe other diseases or mental disorders; 4) Due to the poor compliance of the protocol, the researcher considered that it was not suitable to participate in the study; 5) Pregnant or lactating women and those who have recently had family planning; 6) Patients with impaired liver and kidney function (ALT and AST are twice higher than the upper limit of normal value, and serum creatinine is abnormal).

Design outcomes

Primary

MeasureTime frame
Incidence of diabetes mellitus;

Secondary

MeasureTime frame
Body mass index;Waist hip ratio;blood pressure;glycosylated hemoglobin;Fasting and 2-hour postprandial blood glucose;Fasting insulin;Insulin resistance index(HOMA-IR);Blood?lipid;routine blood test;the routine urine test;Stool routine;liver function;renal function;Syndrome of traditional Chinese Medicine;Constitution of traditional Chinese Medicine;

Countries

China

Contacts

Public ContactXiuge Wang

The Affiliated Hospital of Changchun University of Chinese Medicine

362730191@qq.com+86 0431-86177011

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026